Anti-Human PDCD1 Recombinant Antibody (PD1-17) (CAT#: TAB-0961CL)

This antibody can inhibit binding of PD-L1 to PD-1 and modulate immune responses mediated by TcR and CD28, in particular. It may be used in treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer, and other immune system disorders.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 Reactivity of IgG-converted antibodies with human or mouse PD-1 as determined by ELISA.

Figure 1 Reactivity of IgG-converted antibodies with human or mouse PD-1 as determined by ELISA.

ELISA

Figure 2 An ELISA demonstrating that selected PD-1 antibodies inhibit binding of PD-L1 to PD-1.

Figure 2 An ELISA demonstrating that selected PD-1 antibodies inhibit binding of PD-L1 to PD-1.

FuncS

Figure 3 T-cell proliferation assays demonstrating that co-engagement by TcR and anti-PD-1 antibody PD1-17 or PD-L1.

Figure 3 T-cell proliferation assays demonstrating that co-engagement by TcR and anti-PD-1 antibody PD1-17 or PD-L1.

Fc reduces proliferation. Co-engagement by TcR and anti-PD-1 J110 has no effect on proliferation.

FuncS

Figure 4 Enhanced proliferation of primary T cells by PD1-17 in a soluble form.

Figure 4 Enhanced proliferation of primary T cells by PD1-17 in a soluble form.


Specifications

  • Immunogen
  • Soluble PD-1 fusion protein
  • Host Species
  • Human
  • Derivation
  • scFv phagemid library
  • Type
  • Human antibody
  • Specificity
  • Human
  • Clone
  • PD1-17
  • Applications
  • ELISA, FuncS
  • Related Disease
  • Rheumatoid arthritis (RA)

Applications

  • Application Notes
  • The antibody was validated for ELISA, Functional Assay. For details, refer to Published Data.

Target

  • Alternative Names
  • PDCD1; programmed cell death 1; PD1; PD-1; CD279; SLEB2; hPD-1; hPD-l; hSLE1; programmed cell death protein 1; protein PD-1; systemic lupus erythematosus susceptibility 2

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone PD1-17"

See other products for "PDCD1"

Select a product category from the dropdown menu below to view related products.
Please select product type
Humanized Antibody Products Human Antibody Products Mouse Antibody Products Chimeric Antibody Products Blocking Antibody Products Neutralizing Antibody Products Rabbit Monoclonal Antibody Products Fab Antibody Products IgG Antibody Products ADCC Enhanced Antibody Products ScFv Antibody Products IgM Antibody Products Single Domain Antibody Products Agonistic Antibody Products Antibody Magnetic Beads Hexamer Antibody Products Non-Human Primate (NHP) Antibody Products ScFv-Fc Chimera Products Flow Cytometry (FC) related Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for TAB-0961CL. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare